Teduglutide
Teduglutide
Teduglutide (pronounced as te-doo-gloo-tide) is a glucagon-like peptide-2 (GLP-2) analog used for the treatment of short bowel syndrome (SBS).
Etymology
The name "Teduglutide" is derived from its chemical structure, which is a 33-amino acid polypeptide that is identical to naturally occurring human GLP-2, except for a single amino acid substitution.
Usage
Teduglutide is used in the treatment of short bowel syndrome in adults. Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small intestine and large intestine. Teduglutide works by improving the absorption of fluids and nutrients in the intestines.
Dosage and Administration
Teduglutide is administered through subcutaneous injection. The recommended dosage is 0.05 mg/kg once daily. The injection should be administered at the same time each day.
Side Effects
Common side effects of Teduglutide include abdominal pain, nausea, vomiting, headache, cold symptoms, and skin rash or itching. Serious side effects may include intestinal obstruction and gallbladder disease.
Related Terms
- Glucagon-like peptide-2
- Short bowel syndrome
- Subcutaneous injection
- Intestinal obstruction
- Gallbladder disease
External links
- Medical encyclopedia article on Teduglutide
- Wikipedia's article - Teduglutide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski